Search results
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
Merck (MRK) Gets CHMP Nod for Keytruda in Adjuvant Lung Cancer
Zacks via Yahoo Finance· 9 months agoMerck's (MRK) Keytruda gets a positive CHMP opinion, recommending the approval of the drug for the...
Merck's lung cancer drug combo fails trial in setback for new therapy class
Reuters via AOL· 6 months agoMerck's experimental anti-TIGIT drug vibostolimab in combination with its approved therapy Keytruda...
Merck's (MRK) Keytruda-Lynparza Combo Fails 2nd Lung Cancer Study
Zacks via Yahoo Finance· 3 months agoMerck's attempt to use the Keytruda-Lynparza combination in certain non-small cell lung cancer...
GSK's (GSK) PD-1 Inhibitor Drug Meets Lung Cancer Study Goal
Zacks via Yahoo Finance· 2 years agoGSK's (GSK) mid-stage study, evaluating the combination of its cancer drug Jemperli with...
FDA approves new Bristol Myers drug for lung cancer
BioPharma Dive via Yahoo Finance· 7 months agoAcquired via a $4 billion biotech buyout, Augtyro is one of an array of new products the pharma hopes will offset patent expirations for current top...
Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues
Investor's Business Daily· 2 years agoThe Food and Drug Administration approved Mirati Therapeutics' rival to Amgen's lung cancer drug,...
Merck puts KRAS cancer drug competitor to the test
BioPharma Dive via Yahoo Finance· 2 months agoDive Brief: Merck & Co. has begun a large clinical trial testing an experimental cancer drug it’s developing for tumors that harbor mutations in a...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 week agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 2 months agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
